Alfredo Iloreta, MD
Urology · Topeka, KSNPI 1790751576
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.7% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Astellas Pharma US Inc at 33.8% of the total. That places this record below the midpoint for urology clinicians in KS, where the typical reported total is $2,717.
Across 67 payments — averaging $20.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$461
- Pfizer$146
- Johnson & Johnson$137
- AbbVie$74
- Myriad Genetic Laboratories, Inc.$55
- Profound Medical Corp.$55
- plus $436 from 19 others
What the payments were for
- Food & beverage$1,27894%
- Education$856%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 20 | $461 |
| Pfizer | 8 | $146 |
| Johnson & Johnson | 5 | $137 |
| AbbVie(2 entities) | 5 | $74 |
| Myriad Genetic Laboratories, Inc. | 3 | $55 |
| Profound Medical Corp. | 1 | $55 |
| Blue Earth Diagnostics | 3 | $44 |
| Boston Scientific | 2 | $42 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Endo Pharmaceuticals Inc. | 2 | $31 |
| Teleflex LLC | 1 | $30 |
| Myovant Sciences Inc. | 2 | $25 |
| Janssen Scientific Affairs, LLC | 1 | $25 |
| Medtronic | 1 | $23 |
| BD | 1 | $20 |
| Neotract Inc. | 1 | $20 |
| Ambu Inc. | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Tolmar Pharmaceuticals, Inc. | 1 | $17 |
| Cook Medical LLC | 1 | $16 |
| KARL Storz Endoscopy-america | 1 | $14 |
| Coloplast | 1 | $14 |
| Olympus America Inc. | 1 | $14 |
| Urogen Pharma, Inc. | 1 | $12 |
| Rochester Medical Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYRBETRIQ$110
How this compares
$1,364 in reported general payments places this provider in the 35th percentile of 111 urology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 399 | $4,549 |
| Finasteride | 371 | $3,897 |
| Silodosin | 18 | $1,280 |
| Dutasteride | 15 | $577 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $283 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 52 | $148 |
| Ciprofloxacin Hcl | 40 | $147 |
| Cephalexin | 47 | $113 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 11 | $105 |
| Allopurinol | 11 | $42 |
Paid to pharmacies, not to this prescriber.
Other urology in Topeka
- Loren SmithTopeka$4K
- Bradley RuppTopeka$3K
- Timothy RichardsonWichita$493K
- Wilson MolinaKansas City$239K
- Bristol WhilesKansas City$163K
- Jeffrey HolzbeierleinKansas City$78K
- Ahmad El-ArabiKansas City$55K
- David DucheneKansas City$33K
- Jason AnastOverland Park$31K
- Son NguyenMerriam$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.